Discover more near‑term opportunities with better event intelligence.
Fundz combines its own real-time funding and M&A intelligence with executive moves, hiring shifts and other company changes, weighs each signal against your ideal customer profile, and delivers a ranked daily shortlist with the context and decision maker to contact. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Acquiring Company
Japan Lifeline
Acquired Company
Cross Vascular, Inc.
Solana BeachBiotechnologyHealth CareMedicalMedical DeviceBiotechnologyDescription
Japan Lifeline Co., Ltd. has acquired the U.S.-based company Cross Vascular. This acquisition follows a capital increase and involves changes in specified subsidiaries. The move aims to strengthen Japan Lifeline's market presence in the vascular device sector.
Fundz sees it the moment Japan Lifeline makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Cross Vascular, Inc.?
Cross Vascular, Inc. was acquired by Japan Lifeline. The deal was reported on September 29, 2026. Japan Lifeline is a medical device company specializing in cardiovascular and peripheral vascular disease treatments. Japan Lifeline is privately held and operates in Biotechnology.
When did Japan Lifeline acquire Cross Vascular, Inc.?
Japan Lifeline's acquisition of Cross Vascular, Inc. was reported on September 29, 2026. Japan Lifeline Co., Ltd. has acquired the U.S.-based company Cross Vascular. This acquisition follows a capital increase and involves changes in specified subsidiaries. The move aims to strengthen Japan Lifeline's market presence in the vascular device sector. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Cross Vascular, Inc. do?
Cross Vascular is a U.S.-based company that focuses on developing advanced vascular access technologies. The company aims to improve patient safety and enhance clinical outcomes through its innovative medical devices. It is privately held, operating in Biotechnology, and is based in Solana Beach.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.
5 screens from a live account. No signup.